LEXICON PHARMACEUTICALS INC

LXRX NASDAQ

SwingPyro

Charted by request

EmpireConsulting

Movements depend on corporate news but when good new is announced it has hge upside potential. Traders might play the technical break out too. However you may just have to sit on it for a while you never know when biotechs are going to pop but the wait is worth it when they do.

BarcaGuy

Buy LXRX at $2.30 for target up to $4.30...... see chart

CadillacPat

I like this Chart I like their numbers I like my lines LXRX is testing a new frontier... Stand by

MillionDollarProfit

LXRX Long

mattisbaseball

WATCHING THIS ONE

ganmuru

Trying hard to breakout of the pullback channel. If it breaks out of the channel with volume in addition to a positive PR then the first target would be the gap fill of 4.16-4.25 and the next target would be 4.85. If it breaks down pull back support would be 2.96

MrSmallCap

LXRX is a penny stock that has performed well over the last few weeks but looking at the chart, shares are trading within the gap zone. Volume this week compared to previous weeks is lower. Is that a concern or just a slow week? "Shares of LXRX stock have been on a tear for around a month. This was ever since terminating its partnership agreement with Sanofi....

PennyStock101

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. It drug candidates include XERMELO, Sotagliflozin, LX2761, and LX9211. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX. SHORT...

King-of-WallStreet

..

brandmtrade

Would like to see under yesterday's low around 13.50ish to confirm downward action.